Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06721247 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Oral Intake of Mg in Controlled Asthmatic Patients

Study acronym: Mg in asthma
StatusActive, Not Recruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 14, 2025 (before its estimated November 2, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Trial status: Not Yet Recruiting to Active, Not Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Dec 2, 2025 to Nov 2, 2025
    • Study completion date: Jan 2, 2026 to Nov 2, 2025
    • Start date changed from estimate of Jan 2, 2025 to Nov 2, 2024
    • Site contact updated
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Zagazig University
115 trials monitored
See 3 trials at risk
Asthma
956 trials monitored
See 34 trials at risk
The goal of this clinical trial is to assess the efficacy of oral magnesium supplements in controlled asthmatic patients for proper effective asthma management to reduce frequency of asthma exacerbation \& to test the effect of oral magnesium supplementation on improvement of both clinical symptoms and lung functions in patients with bronchial asthma.. The main questions it aims to answer are: • Can oral supplementation of magnesium play a role in decrease the number of bronchial asthma exacerbations , number of ER visits , number of doctor visits and improve lung function ? Researchers will compare patients on usual treatment according to GINA guidelines 2024 group B and those taking oral magnesium together with the usual group A . Participants will: * Take oral magnesium treatment with usual asthma medications according to GINA guidelines (2024) every day for 1year * Visit the clinic once every 2 weeks for checkups and tests * Keep a diary of their day and night symptoms and the number of times they had activity limitation due to asthma and the number of use reliever.
Trial Details
NCT Number NCT06721247
Lead Sponsor Zagazig University
Conditions
(from sponsor)		 Bronchial Asthma
Related terms Asthma
Enrollment 166 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov